Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection

Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

(2022) Hongjie Xia et al.   Cell Host & Microbe

Nationwide study on SARS-CoV-2 transmission within households from lockdown to reopening, Denmark, 27 February 2020 to 1 August 2020

(2022) Frederik Plesner Lyngse et al.   Eurosurveillance

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection

(2022) Jing Zou et al.   Nature Communications

Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France

(2022) Philippe Colson et al.   JOURNAL OF MEDICAL VIROLOGY

Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 + T-Cell Epitopes Identified in COVID-19 Convalescent Individuals

(2022) Andrew D. Redd et al.   mBio

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2

(2022) Jing Zou et al.   Nature Communications

Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine

(2022) Chaitanya Kurhade et al.   Nature Communications

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

(2021) Xuping Xie et al.   NATURE MEDICINE

Engineering SARS-CoV-2 using a reverse genetic system

(2021) Xuping Xie et al.   Nature Protocols

Neutralizing Activity of BNT162b2-Elicited Serum

(2021) Yang Liu et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3

(2021) Ann R. Falsey et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Infectious cDNA Clone of SARS-CoV-2

(2020) Xuping Xie et al.   Cell Host & Microbe

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

(2020) Mark J. Mulligan et al.   NATURE

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE